Intra Cellular Therapies reported $9K in Ordinary Share Capital for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ordinary Share Capital Change
Acadia Pharmaceuticals ACAD:US USD 16K 0
ALKERMES ALKS:US USD 1.69M 1000
Aptinyx Inc APTX:US USD 677K 0
Biogen BIIB:US USD 100K 0
Bristol Myers Squibb BMY:US USD 292M 0
Cytokinetics CYTK:US USD 93K 8K
Esperion Therapeutics ESPR:US USD 72K 7K
Gilead Sciences GILD:US USD 1000K 0
Halozyme Therapeutics HALO:US USD 135K 3K
Intra Cellular Therapies ITCI:US USD 9K 0
JAZZ PHA JAZZ:US USD 61K 0
Marinus Pharmaceuticals MRNS:US USD 37K 0
Minerva Neurosciences NERV:US USD 1000 0
Nektar Therapeutics NKTR:US USD 19K 0
Neurocrine Biosciences NBIX:US USD 100K 0
Novartis NVS:US USD 890M 0
Prothena PRTA:US USD 479K 11K
Supernus Pharmaceuticals SUPN:US USD 54K 1000
United Therapeutics UTHR:US USD 700K 0
Vanda Pharmaceuticals VNDA:US USD 57K 0